Type
Offshoring/Delocalisation
Country
Norway
Region
Norge; Sør-Østlandet; Vestfold
Location of affected unit(s)
Horten
Sector
Manufacturing
Manufacture of electrical, electronic and optical products
Manufacture of computer, electronic and optical products
26.60 - Manufacture of irradiation, electromedical and electrotherapeutic equipment
New offshoring locations
Austria, United States of America

100 jobs
Number of planned job losses
Job loss
Announcement Date
6 December 2024
Employment effect (start)
1 June 2025
Foreseen end date
1 June 2027

Description

GE Vingmed Ultrasound is offshoring its production of cardiovascular ultrasound equipment, with the effect that 100 jobs will be cut in Horten, Norway. R&D facilities and headquarters will remain in Horten, while production will be moved mainly to Austria and the US.

The first phase will start in summer 2025 and the process will be concluded within approximately two years. CEO Dagfinn Sætre refers to the offshoring as an optimalisation of the organisation, which is being conducted with a heavy heart albeit being necessary.

Trade union representative Anders Bo Bergman describes the affected employees as shocked yet composed, and states that the union has had a solid dialogue with management and believe that the process can be handled well, despite being difficult.

GE Vingmed Ultrasound is a leading provider of cardiovascular and portable ultrasound equipment, first established in Norway as Vingmed in 1968, now owned by General Electric.


Sources

Citation

Eurofound (2024), GE Vingmed Ultrasound, Offshoring/Delocalisation in Norway, factsheet number 202072, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/202072.